Newsroom
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Media Center
Media
Sanofi goes back to Scribe
July 17, 2023
Evaluate
Read Now
Press Release
Sanofi goes back to Scribe
July 17, 2023
Evaluate
Read Now
Media
Sanofi expands research deal with gene editing startup Scribe
July 17, 2023
Biopharma Dive
Read Now
Press Release
Sanofi expands research deal with gene editing startup Scribe
July 17, 2023
Biopharma Dive
Read Now
Press Release
Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June
May 22, 2023
Read Now
Press Release
Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June
May 22, 2023
Read Now
Press Release
Scribe Therapeutics Presents Data on its X-Editing Technologies at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 19, 2023
Read Now
Press Release
Scribe Therapeutics Presents Data on its X-Editing Technologies at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 19, 2023
Read Now